GET THE APP

Analysis of Circular Ribosome Expression Profiles in Leishmaniasis
..

Malaria Control & Elimination

ISSN: 2470-6965

Open Access

Opinion - (2022) Volume 11, Issue 4

Analysis of Circular Ribosome Expression Profiles in Leishmaniasis

Maria Alberto*
*Correspondence: Maria Alberto, Department of Public Health Research, West University of Timișoara, Bulevardul Vasile Pârvan 4, Timișoara 300223, Romania, Email:
Department of Public Health Research, West University of Timișoara, Bulevardul Vasile Pârvan 4, Timișoara 300223, Romania

Received: 07-Jul-2022, Manuscript No. mcce-22-80947; Editor assigned: 09-Jul-2022, Pre QC No. P-80947; Reviewed: 23-Jul-2022, QC No. Q-80947; Revised: 28-Jul-2022, Manuscript No. R-80947; Published: 02-Aug-2022 , DOI: 10.37421/2470-6965.2022.11.187
Citation: Alberto, Maria. “Analysis of Circular Ribosome Expression Profiles in Leishmaniasis.” Malar Contr Elimination 11 (2022):187.
Copyright: © 2022 Alberto M. This is an open-access article distributed under the terms of the creative commons attribution license which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Introduction

Leishmaniasis is a tropical disease that has a significant impact on global public health. Leishmaniasis is the third most common cause of morbidity among parasitic diseases, following malaria and schistosomiasis. Circular RNAs (circRNAs) are a new class of noncoding RNAs that regulate biological and developmental processes. However, no research on the function of circRNAs in leishmaniasis has been published. This is the first study to look at the circRNA expression profiles in leishmaniasis. The potential function of the host genes of differentially expressed circRNAs was determined using GO and KEGG analyses. R software and the STRING database were used to analyse the circRNA-miRNA-mRNA regulatory network and protein-protein interaction (PPI) networks, respectively. A total of 4664 significant differentially expressed circRNAs were identified and compared to controls; 1931 were up-regulated and 2733 were down-regulated. Host genes enriched in ubiquitin-mediated proteolysis, endocytosis, the MAPK signalling pathway, renal cell carcinoma, autophagy, and the ErbB signalling pathway were found in differentially expressed circRNAs.

Description

Leishmaniasis is a parasitic disease that is caused by an obligate intracellular pathogen. In terms of disability adjusted life years, leishmaniasis is the third leading cause of morbidity after malaria and schistosomiasis (DALYs). However, it is the second leading cause of death after malaria. According to published reports, leishmaniasis-endemic areas include 101 countries and approximately 350 million people. The majority of leishmaniasis patients live in impoverished areas, making prevention, diagnosis, and treatment difficult [1-3]. As a result, leishmaniasis affects over 2 million people worldwide each year, resulting in an estimated 40,000 deaths. This parasite also has a high recurrence rate; patients may relapse 6-12 months after receiving treatment. Furthermore, if left untreated, patients can develop multisystem disease or a secondary infection, which can lead to death. Detecting pathogens in bone marrow aspirate smears or cultures is the traditional method of diagnosing leishmaniasis.

However, bone marrow aspiration is not only painful, but the protozoa density is extremely low, making the diagnosis difficult. Furthermore, because visceral leishmaniasis has no distinct clinical symptoms, it is easy to confuse it with other diseases, particularly in endemic areas. As a result, epidemiological investigations are also required. Furthermore, the occurrence of minimally symptomatic, completely asymptomatic, and subclinical disease is regarded as an important aspect of the epidemiology of visceral leishmaniasis, necessitating clinicians to identify additional leishmaniasis epidemiological characteristics. As a result, it is critical to investigate the mechanism of visceral leishmaniasis in order to develop effective diagnostic biomarkers. Circular RNAs (circRNAs) were discovered in RNA viruses for the first time in 1976. Thousands of circRNA species have been identified as a result of the advancement of high-throughput sequencing technology, and the number is still growing. Although circRNAs are a new type of non-coding RNA with covalent closed-loop structures, some circRNAs have the ability to code for proteins.

Zoonotic diseases have a significant impact on human health as a result of their impact on animals and the environment. In order to reduce the harm caused by zoonotic diseases, this study discovered biomarkers of leishmaniasis based on the different expressions of circRNAs in patients. As a result, high-throughput sequencing was used to identify the differentially expressed circRNAs and miRNAs. Furthermore, gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes were used to examine the functionals and pathways of host genes [4,5]. As a result, circRNAs are more stable. Many studies have shown that they are linked to a variety of diseases such as cancer, cerebrovascular disease, systemic lupus erythematosus, and others. However, no research on the function and molecular mechanisms of circRNAs in leishmaniasis has been published.

Conclusion

According to the GO enrichment analysis results, host genes may play an important role in the occurrence of leishmaniasis. The top five significant signal pathways identified by KEGG pathway analysis are ubiquitin-mediated proteolysis, endocytosis, the MAPK signalling pathway, renal cell carcinoma, autophagy, and the ErbB signalling pathway. Three of these five significant signalling pathways have been linked to leishmaniasis.

References

  1. Taoufiq, Zacharie, Paco Pino, Nadine N'dilimabaka and Issam Arrouss, et al. "Atorvastatin preventsPlasmodium falciparum cytoadherence and endothelial damage."Malar J10 (2011): 1-9.
  2. Google Scholar, Crossref, Indexed at

  3. Reis, Patricia A., Vanessa Estato, Tathiany I. Da Silva and Joana C. d'Avila, et al. "Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria."PLoS Pathog8 (2012): e1003099.
  4. Google Scholar, Crossref, Indexed at

  5. Souraud, Jean-Baptiste, Sébastien Briolant, Jérome Dormoi and Joel Mosnier, et al. "Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model."Malar J11 (2012): 1-9.
  6. Google Scholar, Crossref, Indexed at

  7. Van Vught, Lonneke A., Brendon P. Scicluna, Maryse A. Wiewel and Arie J. Hoogendijk, et al. "Comparative analysis of the host response to community-acquired and hospital-acquired pneumonia in critically ill patients." Am J Respir Crit Care Med194 (2016): 1366-1374.
  8. Google Scholar, Crossref, Indexed at

  9. Wan, You-Dong, Tong-Wen Sun, Quan-Cheng Kan and Fang-Xia Guan, et al. "Effect of statin therapy on mortality from infection and sepsis: A meta-analysis of randomized and observational studies."Crit Care18 (2014): 1-13.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 1187

Malaria Control & Elimination received 1187 citations as per Google Scholar report

Malaria Control & Elimination peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward